Abstract
Mental retardation (MR) is a common disorder frequently of unknown origin. Because there are few studies regarding MR and inborn errors of metabolism (IEM), we aimed to identify patients with IEM from a cohort of 944 patients with unexplained MR. Biochemical examinations such as determination of creatine (Cr) metabolites, acylcarnitines, purine, and pyrimidines in urine were applied. We found seven patients with IEM [three with cerebral Cr deficiency syndromes (CCDS)], one with adenylosuccinate lyase (ADSL) deficiency, and three, born before the neonatal metabolic screening program in Catalonia, with phenylketonuria (PKU). All told, they represent 0.8% of the whole cohort. All of them had additional symptoms such as epilepsy, movement disorders, autism, and other psychiatric disturbances. In conclusion, in patients with MR, it is essential to perform a thorough appraisal of the associated signs and symptoms, and in most disorders, it is necessary to apply specific analyses. In some cases, it is important to achieve an early diagnosis and therapy, which may reduce the morbimortality, and to offer genetic counselling.
Similar content being viewed by others
Abbreviations
- ADSL:
-
Adenylosuccinate lyase
- AGAT:
-
Arginine-glycine amidinotransferase
- CCDS:
-
Cerebral creatine deficiency syndromes
- CDG:
-
Congenital disorders of glycosylation
- Cr:
-
Creatine
- Crn:
-
Creatinine
- CRTR:
-
Creatine transporter deficiency
- DPD:
-
Dihydropyrimidine dehydrogenase
- GAA:
-
Guanidinoacetate
- GAMT:
-
Guanidinoacetate methyltransferase
- GC/MS:
-
Gas chromatography/mass spectrometry
- ¹H-MRS:
-
Proton magnetic resonance spectroscopy
- HPLC:
-
High-pressure liquid chromatography
- HPLC-MS/MS:
-
Electrospray ionization tandem mass spectrometry
- IEM:
-
Inborn error of metabolism
- MMACHC:
-
Methylmalonic aciduria CbLC complementation group
- MMADHC:
-
Methylmalonic aciduria CbLD complementation group
- MR:
-
Mental retardation
- MRI:
-
Magnetic resonance imaging
- OTC:
-
Ornithine transcarbamylase
- PKU:
-
Phenylketonuria
- S-Ado:
-
Succinyladenosine
- SAICAr:
-
Succinylamino-imidazole carboxamide riboside
- SUCLA-2:
-
Succinyl-coenzyme A (CoA) ligase
- UMP:
-
Uridine monophosphate
References
Andrade F, Prieto JA, Elorz J, Martín S, Sanjurjo P, Aldámiz-Echevarría L (2008) Stability of urinary glycosaminoglycans in patients with mucopolysaccharidoses. Clin Chim Acta 388(1–2):73–77
Arias A, Ormazabal A, Moreno J et al (2006) Methods for the diagnosis of creatine deficiency syndrome: a comparative study. J Neurosci Methods 156:305–309
Arias A, Corbella M, Fons C et al (2007) Creatine transporter deficiency: prevalence among patients with mental retardation and pitfalls in metabolite screening. Clin Biochem 40:1328–1331
Artuch R, Colomé C, Sierra C et al (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203
Battaglia A, Carey JC (2003) Diagnostic evaluation of developmental delay/mental retardation: an overview. Am J Med Genet Part C (Semin Med Genet) 117C:1–2
Campistol J, Lambruschini N, Vilaseca MA, Cambra FJ, Fusté E, Gómez L (2001) Hiperfenilalaninemias. In: Sanjunjo P, Baldellou A (eds) Diagnóstico y tratamiento de las enfermedades metabólicas hereditarias. Ergon, Madrid, pp 195–206
Clark AJ, Rosenberg EH, Almeida LS et al (2006) X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology. Hum Genet 119:604−610
Curry C, Stevenson R, Aughton D et al (1997) Evaluation of mental retardation: recommendations of a consensus conference: American College of Medical Genetics. Am J Med Genet 72:468–477
Espinós C, Pineda M, Martínez-Rubio D et al (2009) Mutations in the urocanase gene UROC1 are associated with urocanic aciduria. J Med Genet 46:407–411
García-Cazorla A, Pérez-Dueñas B, Pineda M, Artuch R, Vilaseca MA, Campistol J (2006) Orientation of mental retardation from neurometabolic diseases. Rev Neurol 43(Suppl 1):S187–S192
García-Cazorla A, Wolf NI, Serrano M et al (2009) Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis 32:618−629
Hunter A (2000) Outcome of the routine assessment of patients with mental retardation in a genetics clinic. Am J Med Genet 90:60–68
Jurecka A, Tylki-Szymanska A, Zikanova M, Krijt J, Kmoch S (2008) D-Ribose therapy in four patients with adenylosuccinate lyase deficiency: absence of positive effect. J Inherit Metab Dis. doi:10.1007/s10545-008-0904-z
Lion-Francois L, Cheillan D, Pitelet G et al (2006) High frequency of creatine deficiency syndromes in patients with unexplained mental retardation. Neurology 67:1713–1714
Matilainen R, Airaksinen E, Mononen T, Launiala K, Kaariainen R (1995) A population-based study on the causes of mild and severe mental retardation. Acta Paediatr 84:261–266
Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A et al (2006) GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 67:480–484
Moeschler JB (2008) Genetic evaluation of intellectual disabilities. Semin Pediatr Neurol 15:2–9
Moog U, Die-Smulders C, Martens H, Schrander-Stumpel C, Spaapen L (2008) To test or not to test? Metabolic testing in adolescents and adults with intellectual disability. J Policy Pract Intellect Dis 5:167–173
Newmeyer A, Cecil KM, Schapiro M, Clark JF, Degrauw TJ (2005) Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging. J Dev Behav Pediatr 26:276–282
Papavasiliou AS, Bazigou H, Paraskevoulakos E, Kotsalis C (2000) Neurometabolic testing in developmental delay. J Child Neurol 15:620–622
Ryan R, Sunada K (1997) Medical evaluation of persons with mental retardation referred to psychiatric assessment. Gen Hosp Psychiatry 19:274–280
Salerno C, D'Eufemia P, Finocchiaro R et al (1999) Effect of D-ribose on purine synthesis and neurological symptoms in a patient with adenylosuccinase deficiency. Biochim Biophys Acta 1453:135–140
Salomons GS, Van Dooren SJ, Verhoeven NM et al (2001) X-linked creatine transporter gene (SLC6A8) defect: a new creatine deficiency syndrome. Am J Hum Genet 68:1497–1500
Sempere A, Fons C, Arias A et al (2009) Creatine transporter deficiency in two adult patients with static encephalopathy. J Inherit Metab Dis. doi:10.1007/s10545-009-1083-2
Spiegel EK, Colman RF, Patterson D (2006) Adenylosuccinate lyase deficiency. Mol Genet Metab 89:19–31
Stöckler S, Isbrandt D, Hanefeld F, Schmidt B, Von Figura K (1996) Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man. Am J Hum Genet 58:914–922
Stockler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46:149–166
Tanaka K, West-Dull A, Hine DG, Lynn TB, Lowe T (1980) Gas-chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem 26:1847–1853
Tortorelli S, Hahn SH, Cowan TM, Brewster TG, Rinaldo P, Matern D (2005) The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. Mol Genet Metab 84:137–143
Van Buggenhout GJ, Trijbels JM, Wevers R et al (2001) Metabolic studies in older mentally retarded patients: significance of metabolic testing and correlation with the clinical phenotype. Genet Couns 12:1–21
Van Karnebeek CD, Jansweijer MC, Leenders AG, Offringa M, Hennekam RC (2005a) Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 13:6–25
Van KarnebeeK CD, Sheper FY, Abeling NG et al (2005b) Etiology of mental retardation in children referred to a tertiary care center: a prospective study. Am J Ment Retard 110:253–267
Zhang C, Xu K, Dave UP, Wang Y, Matsumoto I (2000) Inborn errors of metabolism discovered in Asian department of pediatrics and mental retardation research center. J Chromatograph 746:41–49
Acknowledgements
We thank the patients, their families, and the institutions for mentally handicapped persons for their collaboration. The study was financially supported by grants FIS 05/1200, FIS PI051180, CAIXA GIRONA, and the Alicia Koplowitz Foundation. The groups are funded by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Georg Hoffmann
References to electronic databases: OMIM 602360, OMIM 601240, OMIM 300352, OMIM 103050, OMIM 274270, OMIM 300322, OMIM 258900, OMIM 261000, OMIM 311250, OMIM 606054, OMIM 60983, OMIM 611935, OMIM 603921, OMIM 243500, OMIM 231670, OMIM 210200, OMIM 300256, http://www.hgvs.org.mutnomen.
Competing interest: None declared
Rights and permissions
About this article
Cite this article
Sempere, A., Arias, A., Farré, G. et al. Study of inborn errors of metabolism in urine from patients with unexplained mental retardation. J Inherit Metab Dis 33, 1–7 (2010). https://doi.org/10.1007/s10545-009-9004-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-009-9004-y